Terumo Corp
XMUN:TUO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Terumo Corp
XMUN:TUO
|
JP |
|
S
|
Stericycle Inc
DUS:SY9
|
US |
|
C
|
Carnival PLC
F:POH3
|
UK |
|
IPH Ltd
ASX:IPH
|
AU |
|
O
|
Oil States International Inc
XBER:OI2
|
US |
|
Next 15 Group PLC
F:8LS
|
UK |
|
Universal Technical Institute Inc
NYSE:UTI
|
US |
|
K
|
Kao Corp
SWB:KAO
|
JP |
Terumo Corp
Terumo is a Japanese medical device company that makes products used in hospitals, blood centers, and other healthcare settings. Its main businesses include injection and infusion devices, needles, catheters, cardiac and vascular treatment tools, blood management equipment, and products used to collect, process, and transfuse blood. It also sells related disposable items that healthcare workers use every day. The company earns money by selling these products to hospitals, clinics, blood banks, and medical distributors around the world. Some items are one-time-use consumables, which creates repeat demand because healthcare providers need to restock them continuously. Terumo also serves large medical institutions that buy specialized tools for procedures such as vascular intervention, surgery, and blood collection. What makes Terumo's business model distinctive is that it sits in several important parts of the healthcare supply chain at once: routine care, blood management, and advanced interventional medicine. That mix gives it both stable demand from everyday medical consumables and exposure to more specialized procedures that require highly engineered devices.
Terumo is a Japanese medical device company that makes products used in hospitals, blood centers, and other healthcare settings. Its main businesses include injection and infusion devices, needles, catheters, cardiac and vascular treatment tools, blood management equipment, and products used to collect, process, and transfuse blood. It also sells related disposable items that healthcare workers use every day.
The company earns money by selling these products to hospitals, clinics, blood banks, and medical distributors around the world. Some items are one-time-use consumables, which creates repeat demand because healthcare providers need to restock them continuously. Terumo also serves large medical institutions that buy specialized tools for procedures such as vascular intervention, surgery, and blood collection.
What makes Terumo's business model distinctive is that it sits in several important parts of the healthcare supply chain at once: routine care, blood management, and advanced interventional medicine. That mix gives it both stable demand from everyday medical consumables and exposure to more specialized procedures that require highly engineered devices.
Record Revenue: Terumo achieved its highest ever third-quarter and year-to-date revenue, with strong growth especially in North America (up 9% excluding FX).
Profit Beat: Operating profit and adjusted operating profit reached record highs, exceeding company guidance despite tariff and FX headwinds.
Acquisition Integration: Results now include the Leverkusen plant and OrganOx. OrganOx saw revenue up 50% YoY and profit margin expand from 13% to 21%.
Tariffs Offset: Negative tariff impacts (JPY 4.2B) were largely offset by pricing measures (JPY 3.5B), with disciplined cost control helping performance.
Restructuring Costs: Terumo will incur onetime restructuring and acquisition-related costs, aiming for JPY 3B in annualized cost savings from workforce optimization.
Rika & Blood Solutions: Rika product rollout completed, focus now on acquiring new customers; production adjustments have had minimal profit impact.
GS26 Targets: Management reiterated confidence in meeting GS26 targets for revenue growth, 20% operating profit margin, and 10% ROIC by FY26.
